文献速递呼吸危重症与机械通气慢阻肺

无创通气与有创撤机在危重症成人中的比较:系统评价与荟萃分析

Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.
PubMed 文献 · Thorax · 2021-10-29

该系统评价与荟萃分析纳入28项随机及半随机试验共2066例插管成人,比较拔管后立即应用无创通气与继续有创撤机策略,发现无创撤机显著降低死亡率、撤机失败率、肺炎发生率及ICU和住院时间,尤其在COPD患者中获益更明显。

要点

  • 无创撤机显著降低危重症成人死亡率(RR 0.57,95%CI 0.44-0.74)。
  • 无创撤机显著减少撤机失败和肺炎,并缩短ICU及住院时间。
  • COPD患者获益更明确,非COPD患者需更谨慎选择。

核心结论

  • 无创撤机显著降低死亡率、肺炎和撤机相关通气时间,尤其在COPD患者中。
  • 非COPD患者获益不明确或需更仔细选择患者。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、EMBASE、Cochrane对照试验中心注册库、四个会议论文集及文献目录至2020年6月。
  • 纳入28项中等至良好质量的随机和半随机试验,共2066例插管成人,44.6%为COPD。
  • 比较拔管后立即应用无创通气与继续有创撤机,主要结局为死亡率。

主要发现

  • 无创撤机显著降低死亡率(RR 0.57,95%CI 0.44-0.74;高质量证据)。
  • 无创撤机显著降低撤机失败率(RR 0.59,95%CI 0.43-0.81;高质量证据)。
  • 无创撤机显著降低肺炎发生率(RR 0.30,95%CI 0.22-0.41;高质量证据)。
  • 无创撤机缩短ICU停留时间(MD -4.62天,95%CI -5.91至-3.34)和住院时间(MD -6.29天,95%CI -8.90至-3.68)。
  • 无创撤机缩短撤机相关通气时间(MD -0.57,95%CI -1.08至-0.07)并降低气管切开率。

关键数值与推荐

  • 死亡率RR 0.57(95%CI 0.44-0.74),撤机失败RR 0.59(95%CI 0.43-0.81),肺炎RR 0.30(95%CI 0.22-0.41)。
  • ICU停留时间MD -4.62天(95%CI -5.91至-3.34),住院时间MD -6.29天(95%CI -8.90至-3.68)。
  • 撤机相关通气时间MD -0.57(95%CI -1.08至-0.07),气管切开率降低。
  • COPD患者亚组中死亡率、肺炎、再插管和ICU停留时间显著低于混合人群试验。

临床怎么用

  • 对符合条件的危重症成人,可考虑拔管后立即应用无创通气作为撤机策略。
  • COPD患者采用无创撤机获益更明确,应优先考虑。
  • 非COPD患者应用无创撤机需更仔细评估和选择。

局限性

  • 非COPD患者获益不明确,需更谨慎选择患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extubation to non-invasive ventilation (NIV) has been investigated as a strategy to wean critically ill adults from invasive ventilation and reduce ventilator-related complications. METHODS: We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, proceedings of four conferences and bibliographies (to June 2020) for randomised and quasi-randomised trials that compared extubation with immediate application of NIV to continued invasive weaning in intubated adults and reported mortality (primary outcome) or other outcomes. Two reviewers independently screened citations, assessed trial quality and abstracted data. RESULTS: We identified 28 trials, of moderate-to-good quality, involving 2066 patients, 44.6% with chronic obstructive pulmonary disease (COPD). Non-invasive weaning significantly reduced mortality (risk ratio (RR) 0.57, 95% CI 0.44 to 0.74; high quality), weaning failures (RR 0.59, 95% CI 0.43 to 0.81; high quality), pneumonia (RR 0.30, 95% CI 0.22 to 0.41; high quality), intensive care unit (ICU) (mean difference (MD) -4.62 days, 95% CI -5.91 to -3.34) and hospital stay (MD -6.29 days, 95% CI -8.90 to -3.68). Non-invasive weaning also significantly reduced the total duration of ventilation, duration of invasive ventilation and duration of ventilation related to weaning (MD -0.57, 95% CI -1.08 to -0.07) and tracheostomy rate. Mortality, pneumonia, reintubation and ICU stay were significantly lower in trials enrolling COPD (vs mixed) populations. CONCLUSION: Non-invasive weaning significantly reduced mortality, pneumonia and the duration of ventilation related to weaning, particularly in patients with COPD. Beneficial effects are less clear (or more careful patient selection is required) in non-COPD patients. PROSPERO REGISTRATION NUMBER: CRD42020201402.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Burns KEA, Stevenson J, Laird M, et al. Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis. Thorax. 2021. PMID: 34716282. doi:10.1136/thoraxjnl-2021-216993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。